Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Fexofenadine vs Montelukast in Asthma
NCT00045955Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fexofenadine in asthma, sponsored by Sanofi. Started Feb 2002; status: completed.
02
Drugs
fexofenadine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00045955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045955.